NCOR2 and ovarian carcinoma: In larger cohort studies of ovarian cancer transcriptomes showed NCOR2 as a biomarker for resistance (Fekete et al., 2020); lower expression observed in the Indian Cohort might be a good predictor of chemotherapy response.